# Earli

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/earli

- Industry: Biotechnology
- Headquarters: Redwood City, US
- Website: www.earli.com
- Total disclosed funding: $60M
- Latest round: Series A (Jan 6, 2021)
- Investors on record: 7

## About

Based in California, US, and founded in 2018 by Chief Executive Officer Cyriac Roeding, co-founder Sam Gambhir and Chief Scientist Officer David Suhy, Earli, Inc. operates as a developer of cancer treatment devices used to detect biomarkers in blood, urine, or breath for early treatment of cancer. In October 2024, Earli, Inc. raised an undisclosed amount in venture funding from new investor GLIN Impact Capital.

Earli, Inc. developed a platform known as the synthetic biopsy platform, which is a transformative approach to cancer diagnostics. The company’s technology prompts cancer cells to produce synthetic biomarkers, which can be detected via imaging technologies such as PET scans. In addition, the firm’s platform aids in early cancer detection but also has therapeutic applications by activating the immune system to target and destroy cancer cells. It offers a synthetic biopsy approach that enhances the sensitivity and specificity of cancer detection for an earlier diagnosis, allowing pharmaceutical and biotech companies to create personalized treatments. 

The company plans to use the October 2024 funding for future expansion and improving survival rates and side effects for cancer patients.

## Funding rounds

- Series A, Jan 6, 2021, $40M — Menlo Ventures, Khosla Ventures, Andreessen Horowitz, Casdin Capital, Perceptive Advisors, Sands Capital Alternatives
- Seed, Sep 17, 2018, $20M — Menlo Ventures, Andreessen Horowitz, ZhenFund

## Investors

- Menlo Ventures (https://capitalatlas.ai/funds/menlo-ventures) — Seed, Series A
- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Seed, Series A
- ZhenFund (https://capitalatlas.ai/funds/zhenfund) — Seed
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series A
- Perceptive Advisors (https://capitalatlas.ai/funds/perceptive-advisors) — Series A
- Sands Capital Alternatives (https://capitalatlas.ai/funds/sands-capital-alternatives) — Series A